Trial · NCT01771627
Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
NCT01771627, Not applicable, Completed, Roswell Park Cancer Institute; results first posted 2020-09-28
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers. Trials, record NCT01771627. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01771627
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
- NCT number
- NCT01771627
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 300 participants, actual
- Lead sponsor
- Roswell Park Cancer Institute
- Conditions
- Tobacco Use Disorder
- Interventions
- varenicline, nicotine patch
- First posted
- 2013-01-18
- Last updated
- 2020-09-28
- Results first posted
- 2020-09-28
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Quit Rate | 4 months | The quit rate at 4 months will be compared between the 2 groups, using a logistic regression analysis with a 2-side 95% confidence interval. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Quit Rate | 4 months | self reported abstinence | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Quit Rate | Arm I (Varenicline) | 13 | Participants | ||
| Quit Rate | Arm II (Nicotine Patch) | 23 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Arm I (Varenicline) | 200 | |
| Overall Study | STARTED | Arm II (Nicotine Patch) | 100 | |
| Overall Study | COMPLETED | Arm I (Varenicline) | 92 | |
| Overall Study | COMPLETED | Arm II (Nicotine Patch) | 50 | |
| Overall Study | NOT COMPLETED | Arm I (Varenicline) | 108 | |
| Overall Study | NOT COMPLETED | Arm II (Nicotine Patch) | 50 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Arm I (Varenicline) | 0 | 200 |
| Total, all-cause mortality | Arm II (Nicotine Patch) | 0 | 100 |
| Total, other adverse events | Arm I (Varenicline) | 0 | 200 |
| Total, other adverse events | Arm II (Nicotine Patch) | 0 | 100 |
| Total, serious adverse events | Arm I (Varenicline) | 0 | 200 |
| Total, serious adverse events | Arm II (Nicotine Patch) | 0 | 100 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 37142273 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Arm I (Varenicline) vs Arm II (Nicotine Patch): Quit Rate | Trial comparisons |
| Arm I (Varenicline) vs Arm II (Nicotine Patch): deaths from any cause | Trial comparisons |
| Arm I (Varenicline) vs Arm II (Nicotine Patch): serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01771627
GET https://conductscience.org/api/trials/v1/NCT01771627/registered